ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,716,888, issued on Aug. 25, was assigned to Jong-Baeck Lim (Seoul, South Korea).
"Composition for diagnosis or treatment of anticancer drug resistance" was invented by Jong-Baeck Lim (Seoul, South Korea), Jae-Il Choi (Seoul, South Korea) and Hye Won Chung (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition for diagnosing resistance to a combination of ECF (Epirubicin, Cisplatin and 5-Fluorouracil; ECF), which is used for the treatment of gastric cancer, and a diagnostic kit comprising the same. In order to solve a problem that cancer recurrence and drug resistance occur due to an increase in ...